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Introduction
Quantitative myocardial perfusion to assess impaired
coronary vasoreactivity has been used to identify subcli-
nical atherosclerosis. Impaired coronary vasodilation has
been observed in patients with cardiac risk factors in
the MESA cohort. The coronary vasodilator response in
patients with angiographically normal coronary arteries/
minimal stenosis is not known. The purpose of this
study was to compare the stress myocardial blood flow
(MBF) of patients with normal coronaries/minimal ste-
nosis with normal volunteers.
Hypothesis
Patients with angiographically normal coronaries/mini-
mal stenosis have impaired vasodilator response when
compared to normal volunteers.
Methods
Twenty patients with normal coronaries/minimal steno-
sis on coronary CT angiography had also undergone
stress MR with regadenoson. Seventeen healthy normal
volunteers with Framingham score less than 1% under-
went stress testing with regadenoson. Using a SSFP
Figure 1 Study Design.
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perfusion sequence, stress imaging was done 70 seconds
post regadenoson injection. All patients and volunteers
received aminophylline after stress imaging. Rest ima-
ging was done 20 minutes later. Myocardial blood flow
(MBF) in ml/min/g and myocardial perfusion reserve
(MPR) were quantified using a fully quantitative model
constrained deconvolution (MCD).
Results
Stress MBF (mean ± standard error) was higher in nor-
mal volunteers (3.72 ± 0.18) than patients (2.78 ± 0.14),
p=.0002. When stratified by risk factors (0-1, >1) the
stress MBF of patients with >1 risk factor was signifi-
cantly lower than young, healthy, normal volunteers
(2.64± 0.12 vs. 3.72± 0.18, p= 0.00005). Figures 1 and 2.
Conclusions
Despite angiographically normal coronaries/minimal ste-
nosis on CT, patients referred for stress testing have
impaired coronary vasodilator response relative to
young, healthy normal volunteers. The magnitude of
this effect is larger in patients with >1 risk factor.
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Figure 2 Rest, Stress MBF and MPR between normal volunteers and
patients.
Figure 3 Rest and Stress MBF in normal volunteers and patients
stratified by risk factors.
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